Related Experiment Video
Updated: Aug 15, 2026

06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
First year of mass screening for prostatic cancer in Yaizu city
1Urology Service, Yaizu City Hospital, Yaizu-shi, Japan. kkawbe@tth-japanpost.jp
Aktuelle Urologie
|October 21, 2003
Abstract:
Three thousand one hundred and twenty men out of the target population of 22,195 men underwent PSA (prostatic specific antigen) determinations as the mass screening test for CAP (prostatic cancer). Three hundred and sixty men showed high (> or = 4.0 ng/ml) PSA values and proceeded to the secondary examinations. Prostatic biopsies were done on two hundred and twelve men, 35 % (74) of them had CAP. The detection rate was 2.4 % of the total examinees.

